Medicare Enrolled
Dr. Wasim Ahmar, MD
Interventional Cardiology · Longwood, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ahmar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmar? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmar
Dr. Wasim Ahmar is an interventional cardiology in Longwood, FL, with 20 years in practice. Based on federal Medicare data, Dr. Ahmar performed 7,057 Medicare services across 3,266 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmar received a total of $10,980 from 46 pharmaceutical and/or device companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 14% volume in FL$ $10,980 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,057
Medicare services
Top 14% in FL for interventional cardiology
3,266
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~353 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,552 | $0 | $2 |
| Regadenoson injection (Lexiscan) for heart stress test | 748 | $44 | $107 |
| Office visit, established patient (30-39 min) | 728 | $90 | $220 |
| Electrocardiogram (EKG), 12-lead | 650 | $10 | $42 |
| Chronic care management, first 20 min/month | 524 | $49 | $80 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 372 | $320 | $1,600 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 215 | $54 | $200 |
| Office visit, established patient (20-29 min) | 202 | $64 | $149 |
| Echocardiogram, transthoracic | 194 | $143 | $529 |
| Heart muscle strain imaging | 194 | $29 | $124 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 183 | $2,108 | $4,406 |
| Nuclear medicine study of heart muscle blood flow by pet | 183 | $142 | $354 |
| Hospital follow-up visit, high complexity | 132 | $94 | $211 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 104 | $140 | $373 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 93 | $49 | $100 |
| Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | 81 | $1,033 | $2,781 |
| EKG interpretation and report | 81 | $6 | $35 |
| Office visit, established patient, complex (40-54 min) | 75 | $130 | $296 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 64 | $19 | $59 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 63 | $27 | $36 |
| Remote pacemaker/defibrillator monitoring, 90 days | 55 | $15 | $69 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 54 | $360 | $470 |
| New patient office visit (30-44 min) | 53 | $69 | $229 |
| Ultrasound of leg arteries or artery grafts | 47 | $183 | $503 |
| Remote pacemaker monitoring, 90 days | 45 | $21 | $73 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 42 | $45 | $191 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 38 | $9 | $43 |
| Injection, midazolam hydrochloride, per 1 mg | 37 | $0 | $0 |
| Initial hospital admission, moderate complexity | 35 | $98 | $285 |
| New patient office visit (45-59 min) | 29 | $110 | $344 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $315 | $722 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 22 | $829 | $3,241 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $17 | $63 |
| Programming of dual lead pacemaker system | 17 | $57 | $130 |
| Ultrasonic guidance for blood vessel access | 16 | $31 | $78 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 16 | $39 | $198 |
| Injection, fentanyl citrate, 0.1 mg | 16 | $0 | $0 |
| New patient office visit, complex (60-74 min) | 14 | $140 | $425 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 13 | $816 | $3,896 |
| Ultrasound of both sides of head and neck blood flow | 13 | $129 | $385 |
| Review by radiologist of abdominal aorta image | 11 | $102 | $559 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
48.5% medium
47.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,980
Total received (2018-2024)
Avg $1,569/year across 7 years
Top 44% in FL for interventional cardiology
46
Companies
249
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,438 (95.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$542 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,402
2023$1,907
2022$1,528
2021$1,668
2020$1,170
2019$1,058
2018$1,248
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,582
Cardiovascular Systems Inc.
$842
Medtronic Vascular, Inc.
$660
BIOTRONIK INC.
$645
Janssen Pharmaceuticals, Inc
$607
Astellas Pharma US Inc
$542
Abbott Laboratories
$520
Kestra Medical Technology Services, Inc.
$472
E.R. Squibb & Sons, L.L.C.
$392
Philips Electronics North America Corporation
$365
Bard Peripheral Vascular, Inc.
$345
Novo Nordisk Inc
$281
Merck Sharp & Dohme LLC
$274
Novartis Pharmaceuticals Corporation
$264
MEDICOMP INC
$233
PFIZER INC.
$219
CeloNova BioSciences, Inc.
$181
ABIOMED
$181
Amgen Inc.
$178
Impulse Dynamics (USA) Inc.
$178
Stryker Corporation
$172
SANOFI-AVENTIS U.S. LLC
$162
AstraZeneca Pharmaceuticals LP
$159
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$154
Boston Scientific Corporation
$152
Terumo Medical Corporation
$143
Integra LifeSciences Corporation
$140
Biosense Webster, Inc.
$121
Avantec Vascular Corporation
$117
Esperion Therapeutics, Inc.
$112
CARDIVA MEDICAL, INC.
$98
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Alnylam Pharmaceuticals Inc.
$52
Baxter Healthcare
$50
Edwards Lifesciences Corporation
$46
Chiesi USA, Inc.
$41
Merck Sharp & Dohme Corporation
$38
Kiniksa Pharmaceuticals International, plc
$29
LivaNova USA, Inc.
$26
Siemens Medical Solutions USA, Inc.
$24
CHIESI USA, INC.
$22
Daiichi Sankyo Inc.
$20
ATRICURE, INC.
$19
AngioDynamics, Inc.
$15
Bardy Diagnostics, Inc.
$15
Amarin Pharma Inc.
$14
Top 3 companies account for 28.1% of total payments
Associated products mentioned in payments ›
(4066) Tack Endo Sys ATK · (4067) Tack Endo Sys BTK · AMPLATZER · AVEIR · Arcalyst · Artis Q ceiling · Assure WCD · Azure · BELSOMRA · BILAYER WOUND MATRIX BWM · BIOMONITOR · BRILINTA · BioMonitor · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CONFIRM RX · CROSSER · CardioMEMS HF System · Carnation Ambulatory Monitor · Claria MRI · Corlanor · ELIQUIS · ENSITE PRECISION · ENTRESTO · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · GALLANT · GENERAL TACHY · HARMONY · Hillrom - Cardiac Ambulatory Monitor · IGT D Peripheral · INJECTAFER · Image Guided Therapy Devices _ Peripheral · Impella · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · LEQVIO · LEXISCAN · LINQ II · LUTONIX · Lexiscan · LifeVest · MAKO · MICRA · MULTAQ · Micra · Mitra Clip system · NEXLETOL · ONPATTRO · OPTIMIZER · Optimizer · Orsiro · Ozempic · PRALUENT · Peripheral Orbital Atherectomy System · ProtekDuo · Quadra Assura CRT Defibrillator · REVEAL LINQ · RYBELSUS · Repatha · Resolute · Rivacor · Rotarex · Rybelsus · SYNERGY ABLATION SYSTEM · TELEPATCH CARDIAC MONITOR · TR Band · Telescope · VENASEAL · VENOVO · VERQUVO · VYNDAMAX · Varithena Administration Pack · Vascepa · Visia AF · WATCHMAN · XARELTO · Zero Gravity
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $156 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
26
Per 100K population
5.5
County median income
$83,030
Nearest hospital
CENTRAL FLORIDA LAKE MONROE HOSPITAL
7.6 mi
7.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ahmar is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmar experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ahmar performed 1,552 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmar receive payments from pharmaceutical companies?
Yes. Dr. Ahmar received a total of $10,980 from 46 companies across 249 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmar's costs compare to other interventional cardiologys in Longwood?
Dr. Ahmar's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Longwood
Browse interventional cardiologys in Longwood ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in FL
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in FL
Which FL interventional cardiologys receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology